Experts discuss the impact of severe eczema on children’s daily lives and the role of newer non-steroidal topical therapies ...
Incyte has announced promising new data from its phase 3b TRuE-AD4 trial of Opzelura (ruxolitinib cream) in adults with moderate atopic dermatitis (AD), revealing significant improvements in clinical ...
Parade on MSN
Ulta's $8 Skincare Staple Has Shoppers Buying Again and Again: 'On My Fourth Purchase of This!'
Changing' Skincare Product Has Shoppers with Eczema Raving: 'Can't Recommend Enough' How you use this retinol cream will ...
Despite being a first-line treatment for CHE, nearly 40% of patients treated with TCS had inadequate treatment response or contraindications to TCS.
In the trial, 62.5% of Opzelura participants achieved a four-point improvement in itch by week eight versus 19.8% on vehicle.
Incyte Announces New Data from Phase 3b TRuE-AD4 Trial of Opzelura® (Ruxolitinib Cream) in Adults with Moderate Atopic ...
Oils, especially those with the potential for significant health benefits, aren't just used for cooking; in some cases, they ...
The unnecessary use of steroid-containing rash creams on children’s delicate skin is triggering serious health risks, including Cushing’s syndrome, immune suppression, and organ damage.
I read an article you wrote about how gut health affects the brain and other parts of the body. Our 19-year-old son has ...
New data from Phase 3 studies show once-daily ZORYVE cream helped reduce sleep disruptions in individuals with atopic dermatitis aged ≥2 yearsNew ...
It’s Eczema Awareness Month, and dermatologist Dr Bernard Ho explains why this often misunderstood condition is more than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback